Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Payables (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Payables for 6 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Payables rose 63.27% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, up 63.27% year-over-year, with the annual reading at $4.1 million for FY2025, 63.27% up from the prior year.
  • Payables hit $4.1 million in Q4 2025 for Rapid Micro Biosystems, up from $3.6 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $5.4 million in Q4 2022 to a low of $1.2 million in Q1 2024.
  • Historically, Payables has averaged $2.8 million across 5 years, with a median of $2.6 million in 2025.
  • Biggest five-year swings in Payables: crashed 63.75% in 2023 and later skyrocketed 126.37% in 2025.
  • Year by year, Payables stood at $3.9 million in 2021, then soared by 37.63% to $5.4 million in 2022, then tumbled by 63.65% to $2.0 million in 2023, then grew by 28.48% to $2.5 million in 2024, then skyrocketed by 63.27% to $4.1 million in 2025.
  • Business Quant data shows Payables for RPID at $4.1 million in Q4 2025, $3.6 million in Q3 2025, and $3.3 million in Q2 2025.